← Leaderboards
Peter Christian Albertsen
University Of Connecticut Sch Of Med/Dnt
$191,975
Attributed
$191,975
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39K · FY2005–08$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$191,975 · 6
AHRQ$0 · 1
By mechanism
M01$191,975 · 6
R01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Anne M Kenny$3,404,518
- Adam J Adler$6,337,232
- Jonathan M Covault$7,325,948
- Pamela Taxel$261,998
- Leslie Ann Caromile$1,064,749
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectMaleProstate NeoplasmsHuman Therapy EvaluationPathologic ProcessHealth SurveysBehavioral /Social Science Research TagHelper T LymphocyteHealth Services Research TagNeoplasm /Cancer EpidemiologyQuestionnairesChronic Disease /DisorderInflammationProstatitisQuality Of LifeT LymphocyteHealth Care Service EvaluationHuman DataLongitudinal Human StudyComorbidityOutcomes ResearchPatient /Disease RegistryAge Difference
Grant awards (22)
CLINICAL TRIAL: SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT)$18,011
M01 · FY2008 · RR · contact PI
SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT)$14,116
M01 · FY2007 · RR · contact PI
SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT)$31,219
M01 · FY2006 · RR · contact PI
SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT)$38,959
M01 · FY2005 · RR
Selenium and Vitamin E Cancer Prevention Trial (SELECT)$34,004
M01 · FY2004 · RR
COMPARISON OF TREATMENT EFFICACY FOR PROSTATE CANCER$0
R01 · FY2002 · HS
PROSTATE CANCER PRACTICE PATTERNS AND HEALTH RELATED QUALITY OF LIFE$0
M01 · FY2002 · RR
PATHOGENESIS OF NON BACTERIAL CHRONIC PROSTATITIS$0
M01 · FY2002 · RR
PATHOGENESIS OF NON BACTERIAL CHRONIC PROSTATITIS$4,361
M01 · FY2001 · RR
PROSTATE CANCER PRACTICE PATTERNS AND HEALTH RELATED QUALITY OF LIFE$4,361
M01 · FY2001 · RR
PATHOGENESIS OF NON BACTERIAL CHRONIC PROSTATITIS$0
M01 · FY2001 · RR
PROSTATE CANCER PRACTICE PATTERNS AND HEALTH RELATED QUALITY OF LIFE$0
M01 · FY2001 · RR
PROSTATE CANCER PRACTICE PATTERNS AND HEALTH RELATED QUALITY OF LIFE$0
M01 · FY2001 · RR
PATHOGENESIS OF NON BACTERIAL CHRONIC PROSTATITIS$0
M01 · FY2001 · RR
COMPARISON OF TREATMENT EFFICACY FOR PROSTATE CANCER$0
R01 · FY2001 · HS
PATHOGENESIS OF NON BACTERIAL CHRONIC PROSTATITIS$19,111
M01 · FY2000 · RR
PROSTATE CANCER PRACTICE PATTERNS AND HEALTH RELATED QUALITY OF LIFE$19,111
M01 · FY2000 · RR
PROSTATE CANCER PRACTICE PATTERNS AND HEALTH RELATED QUALITY OF LIFE$4,361
M01 · FY2000 · RR
PROSTATE CANCER PRACTICE PATTERNS AND HEALTH RELATED QUALITY OF LIFE$4,361
M01 · FY2000 · RR
PATHOGENESIS OF NON BACTERIAL CHRONIC PROSTATITIS$0
M01 · FY2000 · RR
COMPARISON OF TREATMENT EFFICACY FOR PROSTATE CANCER$0
R01 · FY2000 · HS
PATHOGENESIS OF NON BACTERIAL CHRONIC PROSTATITIS$0
M01 · FY2000 · RR